Vitae <ul> <li class="show"><span style="font-family: Avenir;"><strong>ISSN Impreso:</strong> 0121-4004</span></li> <li class="show"><span style="font-family: Avenir;"><strong>ISSN electrónico: </strong>2145-2660</span></li> <li class="show"><span style="font-family: Avenir;"><strong>Periodicidad:</strong> cuatrimestral</span></li> <li class="show"><span style="font-family: Avenir;"><strong>Creative Commons:</strong> <a href="" target="_blank" rel="noopener">by-nc-sa</a></span></li> </ul> School of Pharmaceutical and Food Sciences, University of Antioquia en-US Vitae 0121-4004 <h1>Copyright Notice and Open Access Statement</h1> <p align="justify"><span style="font-family: Avenir;">The Journal Vitae works under the Open Access license, and the published manuscripts remain available for the public, both on the Journal's website and in databases, under the <a href="" target="_blank" rel="noopener"><u>Creative Commons license</u></a>, "Noncommercial Attribution" and "Share alike" systems, adopted in Colombia. Hence, when the authors agree to publish in the Journal Vitae, they will not have the right to economic retributions on publications and reproductions through different diffusion media. The documents are freely available to the internet public, permitting users to read, download, copy, distribute, print, search, or link to the full texts and pass them as data to software. The only constraint on reproduction and distribution, should be to give authors control over the integrity of their work and the right to be appropriately acknowledged and cited.</span></p> <h3><span style="font-family: Avenir;">Authors declare that:</span></h3> <ol> <li value="1"> <p align="justify"><span style="font-family: Avenir;">They are the intellectual property owners and are responsible for all the information stated in the article.</span></p> </li> <li value="2"> <p align="justify"><span style="font-family: Avenir;">This manuscript has not been submitted or published in other printed or digital media. They accept the responsibility for the judgments, opinions, and points of view expressed in the published article and, therefore, they exonerate Universidad de Antioquia and Journal Vitae from any process.</span></p> </li> <li value="3"> <p align="justify"><span style="font-family: Avenir;">They exempt Universidad de Antioquia and Journal Vitae from settling conflicts or disputes related to the authorship of the referred article.</span></p> </li> <li value="4"> <p align="justify"><span style="font-family: Avenir;">They accept the revision of the original manuscript by suitable personnel, and they bind themselves to perform the corrections appointed or suggested by the assessors.</span></p> </li> <li value="5"> <p align="justify"><span style="font-family: Avenir;">Therefore, they know the editorial process and will not bind the Editorial Board of the Journal to assume any obligations regarding the volume and issue in which the article is published.</span></p> </li> <li value="6"> <p align="justify"><span style="font-family: Avenir;">They transfer the rights of publication, reprinting, and distribution of the article from the moment of its approval, in print and digital format, without the right to economic rewards, and under the licensing conditions considered relevant by Journal Vitae.</span></p> </li> <li value="7"> <p align="justify"><span style="font-family: Avenir;">They fully authorize Universidad de Antioquia and Journal Vitae to submit the published material to the diverse databases and indexing systems where the Journal can be found to comply with the requirements of the regulatory authorities to maintain the national classification of journals.</span></p> </li> <li value="8"> <p align="justify"><span style="font-family: Avenir;">They will assume the article publication costs established for the current issue, and they will make the payment as soon as they are informed about the volume and the issue in which the final version of the article is published.</span></p> </li> <li value="9"> <p align="justify"><span style="font-family: Avenir;">After the article is published, you can share digital or printed copies in a noncommercial manner. You will be able to use the paper in your institution or company for educational or research purposes, including the use in course programs.</span></p> </li> </ol> <p align="justify"><span style="font-family: Avenir;"><strong>Conflict of interest:</strong> Authors are responsible for recognizing and disclosing any financial or other benefits that could be perceived to bias their work, acknowledging all financial support and any personal connections with potential sponsors. Examples of such conflicts include receiving research funds or honoraria, serving on advisory boards, stock ownership, or employment and consulting arrangements. Authors without such connections should clearly state that they have no financial support or personal relationships that could be perceived to bias their work. All conflicts of interest should be disclosed on the author's identification page of the manuscript.</span></p> Séptimo Congreso Colombiano De Atención Farmacéutica – Encuentro Iberoamericano De Farmacia Hospitalaria Conductual: “Servicios Profesionales Farmacéuticos y Satisfacción de Necesidades de Pacientes y Sistemas De Salud” <p style="font-weight: 400;">La Atención Farmacéutica (AF) es una tecnología en salud orientada a alcanzar, con la intervención del farmacéutico, los mejores resultados posibles en salud, contribuyendo con la utilización efectiva, segura y económica de los medicamentos. Además, la AF incluye actividades que promueven la salud y previenen la enfermedad. Por ello, el concepto de AF incluye todas las intervenciones —procesos y actividades—que realiza el farmacéutico, orientadas al paciente, con el objetivo de conseguir el máximo beneficio en salud posible, disminuyendo el riesgo de problemas de efectividad y seguridad de la farmacoterapia.</p> <p style="font-weight: 400;">En las ediciones anteriores de este congreso se ha logrado: abordar el concepto de AF como tecnología en salud, avanzar en la divulgación de la evidencia y los resultados de la AF, y proyectar la utilización de tecnologías de la cuarta revolución industrial para la AF. Adicionalmente, se ha valorado el papel de la AF en el contexto de la pandemia por COVID-19. En este sentido: a) se han presentado aspectos teóricos y prácticos relacionados con la AF, y aproximaciones a los efectos de dicha tecnología en el propósito de alcanzar los mejores resultados con la utilización adecuada de los medicamentos; b) se ha realizado una aproximación al uso de tecnologías de la industria 4.0, en la optimización de los procesos y resultados de la AF; y c) se ha propendido por el reconocimiento del papel de la AF en el contexto de la postpandemia por COVID-19 (6). En definitiva, acorde con la esencia de la AF, las ediciones de este evento se han direccionado a fortalecer la práctica farmacéutica de actividades orientada al paciente, así como a evidenciar la contribución del farmacéutico a la salud individual y colectiva.</p> <p><span style="font-weight: 400;">En esta séptima versión, la cual se desarrolla en el contexto del trámite legislativo en el Congreso de Colombia de una propuesta de reforma al Sistema de Salud (Proyecto de Ley No. 339 de 2023, Cámara), el programa de nuestro congreso está orientado a evidenciar la contribución de los servicios profesionales farmacéuticos en la satisfacción de las necesidades de pacientes y sistemas de salud.</span></p> Pedro Amariles Muñoz Copyright (c) 2023 Pedro Amariles Muñoz 2023-11-08 2023-11-08 30 3(1) 10.17533/udea.vitae.v30(1)-Suplement